Nanoform Finland
1,108
EUR
-1,77 %
NANOFH
First North Finland
Medical Equipment & Services
Health Care
3.448 investorer følger denne virksomhed
-1,77%
-4,65%
-28,24%
-35,58%
-45,95%
-30,09%
-34,05%
-85,23%
-
-78,06%
nanoform.com/en/section/investors
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Omsætning
2,57 mio.
EBIT %
-874,71 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Finland
NANOFH
Daglig lav / høj pris
1,108 / 1,24
EUR
Markedsværdi
94,77 mio. EUR
Aktieomsætning
188,96 t EUR
Volumen
164 t
Seneste videoer
Finanskalender
Delårsrapport
18.11.2024
Årsrapport
27.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Handelsbanken Funds | 7,1 % | 7,1 % |
Edward Hæggström | 6,3 % | 6,3 % |
Helsinki University Funds | 5,1 % | 5,1 % |
Mandatum Life Insurance Company | 5,0 % | 5,0 % |
The Fourth Swedish National Pension Fund | 4,7 % | 4,7 % |
Varma Mutual Pension Insurance Company | 4,5 % | 4,5 % |
Keel Capital | 4,5 % | 4,5 % |
Arbejdsmarkedets Tillaegspension (ATP) | 4,3 % | 4,3 % |
Danske Invest | 3,9 % | 3,9 % |
Kai Falck | 3,2 % | 3,2 % |
ViserAlle indholdstyper
Nanoform Q3 2024 report: Record number of new projects signed
Invitation to Nanoform's Q3 2024 Report Presentation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools